Table 5.

Most commonly reported variants in each gene and clinically relevant mutations

Gene	Most commonly reported variant by participants	Clinically relevant variants known to be present in the sample
BRAF	c.1799T>A p.(Val600Glu)	c.1799T>A p.(Val600Glu)
EGFR	c.2235_2249del p.(Glu746_Ala750del)	c.2156G>C p.(Gly719Ala); c.2235_2249del p.(Glu746_Ala750del); c.2573T>G p.(Leu858Arg) and c.2582T>A p.(Leu861Gln)
KIT	c.1727T>C p.(Leu576Asn)	c.1504_1509dup p.(Ala502_Tyr503dup) and c.1727T>C p.(Leu576Asn)
KRAS	c.35G>A p.(Gly12Asp)	c.35G>A p.(Gly12Asp), c.175G>A p.(Ala59Thr) c.183A>C p.(Gln61His) and c.351A>C p.(Lys117Asn)
NRAS	c.35G>A p.(Gly12Asp)	c.35G>A p.(Gly12Asp) and c.182A>G p.(Gln61Arg)
PDGFRA	c.1698_1712del and c.2525A>T p.(Asp842Val)	c.2525A>T p.(Asp842Val)
PIK3CA	c.3140A>G p.(His1047Arg)	c.1624G>A p.(Glu542Lys); c.1633G>A p.(Glu545Lys) and c.3140A>G p.(His1047Arg)